Clinical trials
Active, not recruiting Neoplasm Metastasis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 10 |
| 2022 | 7 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 9 |
| Eli Lilly and Company | 3 |
| Novartis Pharmaceuticals | 3 |
| Shanghai Changzheng Hospital | 2 |
| AbbVie | 1 |
| Boehringer Ingelheim | 1 |
| Chinese PLA General Hospital | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Elpiscience (Suzhou) Biopharma, Ltd. | 1 |
| Fudan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 33 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Breast Neoplasms | 8 |
| Colorectal Neoplasms | 4 |
| Neoplasms | 4 |
| Prostatic Neoplasms | 4 |
| Carcinoma | 3 |
| Breast Diseases | 2 |
| Carcinoma, Renal Cell | 2 |
| Lung Neoplasms | 2 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.